Management of the late effects of treatments for gynecological cancer.
OBJECTIVE
As the number of gynecologic cancer survivors grows, there is an increased awareness and need for effective therapy for late side-effects caused by cancer treatments. Several treatment modalities are used to treat gynecologic malignancies, including surgery, radiotherapy, and chemotherapy. Each modality can be responsible for causing late-term side-effects.


RESULTS
There has been an increased awareness of the late detrimental side-effects of cancer treatment, mostly by the use of patient-generated surveys. Effective ways to treat and ameliorate the late side-effects have lagged behind the ability to describe and categorize these effects on patient's quality of life.


CONCLUSIONS
This review will highlight the recent studies to help the clinician caring for gynecologic cancer survivors in recognizing and treating the late effects of cancer therapy.
Gynecologic Oncology, Summa Health System, Akron, OH, USA. Andrewssj@Summahealth.org
Stephen
S
Andrews
Vivian E
VE
von Gruenigen
D000359:Aftercare / Q000379:methods; D000970:Antineoplastic Agents / Q000009:adverse effects; D003072:Cognition Disorders / Q000139:chemically induced; D003131:Combined Modality Therapy / Q000009:adverse effects; D005260:Female; D005833:Genital Neoplasms, Female / Q000628:therapy*; D006801:Humans; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D012735:Sexual Dysfunction, Physiological / Q000209:etiology; D017741:Survivors
D000970:Antineoplastic Agents